Introduction
Cancer is second only to heart disease as the leading cause of death in the United States and colorectal cancer is one of the most prevalent causes of cancerrelated mortality in the western world [1] . Further development of therapeutic and preventative means of controlling this disease is clearly needed, particularly as they pertain to gastrointestinal cancer. Epidemiological studies strongly suggest that nutrition plays an important role in carcinogenesis. Dietary factors have been estimated to account for up to 80% of cancers of the gastrointestinal tract and approximately 30% of cancer morbidity and mortality might be prevented with proper adjustment of diets [2] [3] [4] . Multiple components in fruits, vegetables, herbs and spices have been found to inhibit tumor formation in experimental animals; many studies have focused on polyphenolic compounds in this regard because of their potent biological properties [5] .
Tea (Camellia sinensis) is the second most commonly consumed beverage in the world (an estimated 18-20 billion cups daily) and represents a particularly important source of anti-tumorigenic polyphenols: it is clearly palatable, inexpensive and widely available, and tea exhibits little or no toxic effects in normal, healthy cells. There are three major types of tea: unfermented green tea, semi-fermented oolong tea, and fermented black and red tea. While the chemical composition of teas is complex, the polyphenolic compounds (catechins) constitute the most interesting because of their potent beneficial activity in vivo and in vitro. The major catechins in green tea are EGCG, ECG, EGC, and EC. Green tea contains more catechins than other types of tea and EGCG has been studied more often for its biological activity because it is the most abundant catechin in this beverage. However, many researchers have also studied the other catechins, including ECG, for their biological activities [6, 7] .
The anti-tumor effects of these green tea catechins have been studied at the cell biological level, and the major cellular phenomena induced by the catechins were found to be apoptosis and cell cycle arrest. Potential mechanisms have also been suggested to include anti-oxidative activity [8] , inhibition of enzymes related to tumor promotion such as cyclooxygenase and lipoxygenase [9] , inhibition of activator protein-1 [10] , inhibition of angiogenesis [11] , inhibition of vascular endothelial growth factor receptor phosphorylation [12] , activation of p53 tumor suppressor protein [13] , and inhibition of telomerase activity [14] . However, the high concentration of catechins used in most studies may not be relevant to those obtained by tea drinkers and the effects and precise molecular mechanisms by which catechins other than EGCG induce apoptotic cell death are still largely unknown.
NSAID activated gene (NAG-1) was identified by PCR-based subtractive hybridization as a pro-apoptotic and anti-tumorigenic protein [15] . The human NAG-1 cDNA encodes a secreted protein with homology to members of the TGF-β superfamily and has been previously identified variously as macrophage inhibitory cytokine-1 (MIC-1) [16] , placental transforming growth factor-β (PTGFB) [17] , prostate derived factor (PDF) [18] , growth differentiation factor 15 (GDF-15) [19] , and placental bone morphogenetic protein (PLAB) [20] . It is highly expressed in mature intestinal epithelial cells, but is significantly reduced in human colorectal carcinoma samples and neoplastic intestinal polyps of Min mice [21] . In addition, it has been reported that treatment of prostate cancer cells with recombinant NAG-1 induces apoptosis [22] . These data support the link between NAG-1 and apoptosis with increased expression favoring anti- [29] . While some of these compounds induce NAG-1 expression via the p53 tumor suppressor protein, NSAIDs induce NAG-1 in a p53-independent manner [24] , suggesting that several pathways are involved in the regulation of NAG-1 expression.
In this report, we present NAG-1 as a novel target protein for catechins, particularly ECG, which can induce its expression in a p53 independent manner. In addition, induction of NAG-1 can promote apoptosis and mediate anti-tumorigenic activity. ECG is the most potent NAG-1 inducer tested in this study and the ATF3 transcription factor may be involved in the ECG-induced NAG-1 expression. In addition, we have also investigated signaling pathways affected by ECG and propose herein an overview of how ECG induces apoptosis in human colorectal cancer cells. 
Materials and Methods
Cell lines, Reagents, and Plasmids: Cell lines were purchased from ATCC (Rockville, MD). HCT-116 human colorectal carcinoma cells were maintained in McCoy's 5A medium supplemented with 10% fetal bovine serum (FBS) and Gentamicin (10 µg/ml). Catechins including EGCG, EGC, ECG, and EC were purchased from Sigma (St. Louis, MO), and dissolved in DMSO. HCT-116 p53-/-cells were generously provided by Dr. Bert Vogelstein (John's Hopkins University, Baltimore MD). The pCG-ATF3 construct was kindly provided by Dr. T. Hai (Ohio State University). NAG-1, p53 and actin antibodies were described previously [15, 24, 27] . TSP1, ATF3, and PARP antibodies were purchased from NeoMaker, Santa Cruz, and Cell Signalling, respectively. The pNAG1086/LUC and pNAG41/LUC constructs were previously described [27, 30] . RNA isolation, Northern blot analysis, and RT-PCR: Cells at 60-80% confluence in 10 cm plates were treated at indicated concentrations with EGCG or DMSO in the absence of serum. Total RNAs were isolated using TRIzol reagents (Life Technologies, MD) according to the manufacturer's protocol. Northern blot analysis was performed as described previously [31] . For RT-PCR, five micrograms of total RNAs were reverse transcribed and one tenth volume of synthesized cDNA was then added to a 50 µl PCR reaction mixture with TSP1 gene-specific primers (5'-AGAACGCCAAGTGCAACTAC-3' and 5'-GGAAATCGGTCTCACTGATG-3') , NAG-1 gene-specific primers 
Western blot analysis:
The level of protein expression was evaluated using Western blot analysis with specific antibodies. Cells were grown to 60-80% confluence in 10 cm plates followed by 24 hr treatment in the presence of indicated compounds. Total cell lysates were isolated using RIPA buffer (1X PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS). Proteins (30 µg) were separated by SDS-PAGE and transferred for 1 hr onto nitrocellulose membrane (Schleicher & Schuell, NH). The blots were blocked for 1 hr with 5% skim milk in TBS/Tween 0.05% (TBS-T), and probed with specific antibodies at RT for 4 hr. After washing with TBS-T, the blots were treated with horseradish peroxidase-conjugated secondary antibody for 1 hr and washed several times. Proteins were detected by the enhanced chemiluminescence system (Amersham, IL). Cell proliferation assay: The cell proliferation assay was performed by CellTiter 96 Aqueous Non-Radioactive cell proliferation assay kit (Promega, WI). The assay was carried out as described in the manufacturer's protocol. In the 96-well plates, cells were split into 1,000 cells/well in 100 µl. After 16 hr, cells were treated with various compounds in 96-well plate and incubated for different time points. MTS/PMS solution (20 µl/well) (Promega, WI) was added and incubated for 1 hr. Absorbance at 490 nm was measured using a Microplate reader (ELx800, BIO-TEK Instruments, VT). Apoptosis assay: The DNA content for the sub G1 population was determined by flow cytometry. HCT-116 cells were plated at 3x10 5 cells/well in 6 well plates, incubated for 16 h, and then treated with different compounds in the presence of serum. The cells (attached and floating cells) were then harvested, washed with PBS, fixed by the slow addition of cold 70% ethanol to a total of 1 ml, and stored at 4°C overnight. The fixed cells were pelleted, washed with 50%, 30% ethanol, followed by PBS, and stained in 1 ml of 20 µg/ml propidium iodide (PI), 1 mg/ml RNase in PBS for 20 min. Seven thousand five hundred cells were examined by flow cytometry using Becton Dickinson FACSort equipped with CellQuest software by gating on an area versus width dot plot to exclude cell debris and cell aggregates. Apoptosis was measured by the level of subdiploid DNA contained in cells following treatment with compounds using CellQuest software. Transfection using the luciferase reporter system: HCT-116 cells were plated in 6-well plates at 2x10 5 cells/well in McCoy's 5A or DMEM media, respectively, supplemented with 10% fetal bovine serum. For the co-transfection experiment, 0.5 µg of reporter vector and 0.5 µg of expression vector were transfected with 0.05 µg of pRLnull vector according to the manufacturer's protocol. After 48 hr of transfection, the cells were harvested in 1X luciferase lysis buffer, and luciferase activity was determined and normalized to the pRL-null luciferase activity using the Dual Luciferase Assay Kit (Promega, WI). Superarray assay: HCT-116 p53 -/-cells were seeded into plates 100 mm in diameter.
Once they reached at 60-80% of confluency, vehicle or 50 µM ECG was treated for 24 hrs. Total RNA was extracted using Trizol and cDNA was labeled from 5 µg of total RNA in a reverse-transcription (RT) reaction with biotin-16-dUTP (Roche Diagnostics GmbH). RT reaction was performed using MMLV Reverse Transcriptase (Promega, WI). The labeled cDNA was hybridized to GEArray Q Series Human Cancer PathwayFinder Gene Array (HS-006, SuperArray Bioscience) overnight at 60°C. The membrane used in the present study contained 96 genes that were closely related to cancer, in addition to 4 positive control genes (glyceraldehyde-3-phosphate dehydrogenase, cyclophillin A, ribosomal protein L13A, and β-actin) and 1 negative control (pUC18). After being washed, the membrane was incubated with streptavidin alkaline phosphatase and was finally exposed to CDP-Star alkaline phosphatase chemiluminescent substrate. Statistical analysis: Mean values were compared by two-tailed Student's t test. 
Results
The green tea catechin, ECG induces NAG-1 expression in HCT-116 cells. Green tea contains more catechins than other types of tea [32] and epigallocatechin-3-gallate (EGCG) has been studied most often for its anti-tumorigenic activity because it is the most abundant catechin in this beverage. Therefore, we performed Northern analysis to see if EGCG induces NAG-1 transcripts in HCT-116 cells. As shown in Fig. 1A , NAG-1 is induced by EGCG, with higher expression at 100 µM. This result may indicate that EGCG induces NAG-1 expression at only high concentrations. Next, we asked if other green tea catechins induce NAG-1 expression. While EGCG has been well studied and is known to have pro-apoptotic activity in several cancer cells, other catechins including ECG, EGC, and EC have not been investigated in as much detail. Therefore, HCT-116 cells were treated with 50 µM of EGCG, EGC, ECG, or EC for 24 hrs and Western analysis was carried out. As shown in Fig. 1B , NAG-1 expression was highly induced with ECG treatment, but not with EGCG, EGC, or EC compound. We have also treated with various combinations of two catechins and found that NAG-1 was only expressed when ECG was present (data not shown). We selected two catechins for further analysis, EGCG (a well known anti-tumorigenic catechin) and ECG (the most significant NAG-1 inducer), and treated HCT-116 cells with different concentrations for 24 hrs, then look for NAG-1 protein expression by Western analysis. The tumor suppressor protein p53 was also measured because it is known that the anti-tumorigenic activity of EGCG is known to be mediated by p53 [13, 33] and other polyphenolic compounds including resveratrol and genistein induced NAG-1 expression via p53 [24, 25] . Both compounds increased NAG-1 expression, with the highest NAG-1 induction at 50 µM ECG and 100 µM EGCG (Fig. 1C) . The same membrane was stripped and re-probed with p53 antibody, which showed that the p53 protein was induced by EGCG, but not by ECG. This indicates an obvious link between NAG-1 expression and p53 induction by EGCG, whereas ECG-induced NAG-1 expression seems to be unrelated to p53 expression. Overall, these results suggest that the two catechins may affect different molecular mechanism to induce NAG-1 expression in HCT-116 cells. Examination of Catechin compounds on cell growth rate and apoptosis. NAG-1 expression is linked to apoptosis [15, 17, 23, 34] . To investigate the effects of catechins on the growth of colorectal cancer cells in culture different catechins were added to the culture medium for 48 hrs, at 50 µM concentrations. Sulindac sulfide was used as a positive control for apoptosis in HCT-116 cells [15] . A significant induction of apoptosis was observed when cultures were treated with ECG, whereas other catechins failed to have this effect (Fig. 2A) . Sulindac sulfide was used as a positive control for apoptosis in HCT-116 cells [15] . Next, we examined the ability of different catechins to inhibit cell growth. HCT-116 cells were treated with different catechins for 7 days and the cell growth rate was measured. As shown in Fig. 2B , ECG treatment resulted in the complete inhibition of cell growth, whereas other catechins did not affect any significant inhibition at 50 µM, suggesting that ECG is more potent than any of the other catechins with respect to cell growth arrest. Interestingly, EGCG and EGC treatment slightly promoted cell growth during the time course. This effect has been previously described in human colon cancer cells treated with low concentrations of EGCG [35] . Taken together with previous reports, 50 µM ECG results in growth arrest and enhanced apoptosis in HCT-116 cells, whereas other catechins do not induce apoptosis at the same concentration. PARP cleavage by ECG Since ECG induces cell growth arrest and apoptosis in HCT-116 cells, we examined the effect of ECG treatment on cell morphology and cell death pathways. HCT-116 cells were treated with different catechins and Western analysis was performed to see if poly-[ADP-ribose] polymerase (PARP) produces 2 fragments of ~116 and ~85 kDa. As shown in Fig. 3 , only ECG treatement results in PARP cleavage in HCT-116 cells. The observed cleavage of PARP, a DNA repair enzyme cleaved by caspases during apoptosis, was consistent with previous data showing that ECG induces apoptosis and cell growth arrest. Promoter activity of NAG-1 in the presence of ATF3 To investigate the molecular mechanism at the transcriptional level by which ECG induces NAG-1 expression, the expression of two transcription factors, EGR-1 and ATF3, were examined. EGR-1 has been shown to bind the NAG-1 promoter and transactivate troglitazone-induced NAG-1 expression [27,30], whereas ATF3 has been shown to be induced by several compounds. Interestingly, ATF3 was induced at 12 hr after ECG treatment (Fig. 4A) . In contrast, EGR-1 was not altered by ECG treatment. To see if ATF3 mediates NAG-1 expression at the transcriptional level, we examined the sequences for ATF3 transcription factor binding sites through the 3.5 kb NAG-1 promoter sequences [30] , and found one at the -948 to -955 bp region of the NAG-1 promoter (Fig. 4B, left panel) . The pNAG1086/LUC or pNAG41/LUC promoter constructs were co-transfected with either empty vector or a pCG-ATF3 expression vector. Both NAG-1 constructs do not contain p53 binding sites. As shown in Fig. 4B , ATF3 expression induced NAG-1 promoter activity in pNAG1086/LUC transfection, suggesting that ATF3 mediates NAG-1 expression through the putative ATF3 binding site located at -955 bp promoter region. Other potential pathways affected by ECG. Previous results suggest that p53 is not involved in ECG-induced NAG-1 expression. To confirm the p53 independent mechanism of ECG, we used p53 null HCT-116 cells (HCT-116 p53-/-) and examined NAG-1 expression in the presence of different catechins. As expected, NAG-1 was only induced in ECG-treated cells (Fig. 5A) , further providing evidence that ECG-induced NAG-1 expression is p53 independent. This data is consistent with Fig. 1C , indicating that ECG-induced NAG-1 expression is p53 independent. To examine other potential pathways by which ECG induces antitumorigenic activity in a p53-independent manner, we performed superarray analysis to characterize the mRNA expression profile of cancer-related genes in HCT-116 p53-/-cells. After incubation with or without 50 µM ECG, cellular RNA was extracted, and cancer-related gene expression was analyzed using Superarray TM membranes. Genes that were up-regulated >3.0-fold by ECG were Bcl-x, CDC25A, PAI-1, DNA-PK, Ecadherin, and TSP1, whereas significantly (<0.5 of control) down regulated genes were APAF-1 and RB1 (data not shown). Among these, we further analyzed TSP1 (Fig. 5B) , because its induction can contribute to inhibition of angiogenesis [36] . Oligonucleotide primers were designed for TSP1 as described in Material and Methods and RT-PCR was performed. TSP1 and NAG-1 transcription were markedly up-regulated in HCT-116 p53-/-cells with ECG treatment, whereas the levels of transcription of GAPDH was not affected (Fig. 5C) . We then performed Western analysis of HCT-116 p53-/-cells to confirm that ECG induces TSP1 protein expression. As shown in Fig.5D 
Discussion
Some of the most promising pharmaceutical agents described to date for the prevention of colorectal cancer are the nonsteroidal anti-inflammatory drugs (NSAIDs). NSAID activated gene (NAG-1) has been identified in our laboratory by PCR-based subtractive hybridization as a pro-apoptotic and anti-tumorigenic protein induced by NSAIDs [15] . The human NAG-1 cDNA encodes a secreted protein with homology to members of the TGF-β superfamily and it has been reported that NAG-1 overexpression from a recombinant adenoviral vector results in up to an 80% reduction of MDA-MB-468 and MCF-7 breast cancer cell viability [17] . These data support the evidence that NAG-1 is linked to apoptosis and that it's reduced expression may enhance tumorigenesis. Although highly expressed in mature intestinal epithelial cells and significantly reduced in neoplastic intestinal epithelium [21] , there are conflicting reports of NAG-1 expression in prostate cancer [37] [38] [39] [40] . Thus, more detailed studies are required to elucidate NAG-1 function in prostate carcinogenesis. In contrast, the function of NAG-1 in human colorectal cancer has been well established. NAG-1 overexpression causes suppression of tumor growth in a xenograft animal model and inhibits cell growth in vitro [15] . NAG-1 is induced by several anti-cancer compounds [24, 25, 29, 31] . In this report, we provide further evidence that ECG, an inducer of apoptosis in colorectal cancer cells, induces NAG-1 expression mediated by the ATF3 transcription factor.
Catechins, which are water-soluble substances with limited ability to pass through the plasma membrane of cells, may bind to certain cell surface receptors, thereby provoking receptor-like intracellular signals. In addition, catechins might utilize the kinase cascade in a similar manner to toxic substances or cellular stress. Overall, our understanding of the molecular mechanisms by which catechins exert their anti-tumorigenic effect is not clear, but induction of apoptosis by catechins is one observable fact to explain their anti-tumorigenic activity. Although it is unclear from epidemiologic studies whether green tea has any effect on human colorectal cancer risk [41] , experimental evidence clearly indicates that green tea components induce antitumorigenic activity by apoptosis in colorectal cancer cells [5, 35] . In this report, we provide NAG-1 induction as a novel mechanism of catechin-induced apoptosis, and show that ECG, EGCG, EC, and EGC individually have a variable affect on expression of NAG-1 protein, apoptosis induction and cell growth rate in human colorectal cancer cells. Interestingly, ECG has a distinct mechanism to induce NAG-1 expression in HCT-116 cells. HCT-116 cells contain intact p53 alleles and EGCG (100 µM) induced NAG-1 expression is mediated by p53 protein induction at the transcriptional level. Since EGCG treatment in HCT-116 cells induces the p53 protein and a high concentration of EGCG (100 µM) is known to induce oxidative DNA damage [42] , it is likely that DNA damage causes p53 induction followed by NAG-1 induction in HCT-116 cells. This data also supports previous reports that NAG-1 is regulated by p53 [17,24,34] and EGCG activates the p53 protein [13] .
ECG induces NAG-1 expression in a p53 independent manner as shown in Fig. 2  and 5 . ECG induces NAG-1 expression in cells lacking p53 (Fig. 5 ) and a NAG-1 promoter that lacks the p53 binding site is activated in the presence of ECG (data not shown). Furthermore, p53 protein expression is not induced by ECG (Fig. 1C) . Taken together, ECG induced NAG-1 expression occurs in a p53 independent manner. We therefore investigated other pathways by which ECG might induce NAG-1 expression in Fig. 4 , the ATF3 transcription factor may play an important role in ECG-induced NAG-1 expression. ATF3 is induced by camptothecin and etoposide, agents known to induce apoptosis [43, 44] . Furthermore, ATF3 is highly expressed after sulindac sulfide treatment and may also play an important role in sulindac sulfide-induced apoptosis and anti-tumorigenic activity [45, 46] . Tetracyclineinducible overexpression of ATF3 suppresses cell growth and slows cell cycle progression from G 1 to S phase [47] . In this report, we show that ECG-induced NAG-1 expression is mediated by ATF3 in a p53 independent manner (Fig. 6) . This is interesting because p53 tumor suppressor proteins are often mutated in cancer, suggesting that ECG might be valuable as a therapeutic agent. Indeed, many researchers have investigated gene alteration profiles to search for p53 independent pathways affected by green tea components in neuron [48] , and prostate [49] cancer cells. In this study, we also found several genes that were changed by ECG treatment in human colorectal cancer cells. One of the ECG-induced genes is Thrombospondin-1 (TSP1), which can inhibit angiogenesis and modulate the activity of TGF-β1. It is notable that TSP1 expression was seen earlier than NAG-1 expression following ECG treatment of HCT-116 cells, suggesting that ECG could induce TSP1 expression with subsequent modulation of NAG-1. We are currently investigating the relationship between TSP1 and NAG-1 expression.
It has been reported that ECG and EGCG exhibit different biological activity compared to other catechins in many aspects: EGCG and ECG are more potent free radical scavengers than other catechins [50] ; EGCG and ECG might be potent neuroprotective agents for Parkinson's disease [51] ; and EGCG and ECG are potent inhibitors of fatty-acid synthesis with resultant selective cytotoxic effects on human cancer cells [52] . Thus, EGCG and ECG may be more biologically active than other catechins in green tea. In this report, we further show that EGCG and ECG may affect different mechanisms regarding NAG-1 induction. Although ECG differs from EGCG only by the lack of one hydroxyl group on the B-ring, ECG is more biologically active than EGCG, consistent with previously reported specificity of NAG-1 regulation by other compounds. Many NSAIDs are structurally related to each other but have distinct effects on NAG-1 expression. For instance, sulindac sulfide induces NAG-1 expression whereas sulindac sulfone does not [15] . Another example would be the differential effects of resveratrol and resveratrol derivatives on NAG-1 expression [24] . Changing the hydroxyl group of resveratrol to a methoxy group diminishes NAG-1 induction, compared to resveratrol, indicating that the hydroxyl group may play a pivotal role in the induction of NAG-1. Therefore, it is not surprising that a relatively minute difference in catechin structure greatly affects NAG-1 expression but the molecular basis for this distinction remains to be determined. The concentration of green tea catechins in human plasma has been reported to reach no higher than 1 µM even with consumption of large amounts of the beverage [53] . Higher levels are expected to be present in the lumen of the gastrointestinal tract. Absorption, metabolism and/or degradation would result in lower concentrations in the colonic luminal fluids and, therefore, lower tissue concentrations than we could expect were present in our treated cells. Yang et al., reported that the efficacy of 50% inhibition in cell culture varied, but generally ranged between 22 to 130 µM for EGCG [54] . Taken together with our study, a 50 µM catechin in cell culture reflects a higher range of plasma concentration; however, to know the exact effective concentration in the cell culture, it should be considering the bioability, degradation, as well as metabolite effects of catechins in the cell culture. In summary, the present study demonstrates that green tea catechins (EGCG, ECG, EGC, and EC) exhibit a variety of actions on human colorectal cancer cells, including apoptosis, cell growth, and NAG-1 expression. Many mechanisms may simultaneously contribute to the beneficial effects of catechins in human colorectal cancer. However, p53 independent induction of NAG-1 by green tea catechins, particularly ECG, is one solid molecular mechanism to explain their beneficial effects. Nevertheless, more work is required to elucidate the molecular and clinical chemopreventive effects of green tea on human colorectal cancer. 
